| Filed On | Filing |
|---|---|
| 03 Aug 2020 |
8-K/A: Departure/Election of Directors or Officers; Compensation
As previously reported on a Current Report on Form 8-K filed by Royalty Pharma plc (the “Company”) on June 16, 2020 (the “Form 8-K”), the Company’s Board of Directors (the “Board”) appointed Catherine Engelbert as a member of the Board. ... |
Loading...